Author: Hanju Lee

Awards

Hopkins faculty and startups receive translational funding from TEDCO

Hopkins faculty and startups receive translational funding from TEDCO

This summer, two Hopkins faculty members and two Hopkins startups will receive funding from the Maryland Innovation Initiative (“MII”) to commercialize promising technologies.

MII is a partnership between the state of Maryland and five of the state’s academic research institutions to promote the commercialization of research and is operated by TEDCO. The program fosters the transition of technologies having significant commercial potential from participating universities, including The Johns Hopkins University, to the commercial sector by funding technology validation, market assessment and the creation of start-up companies in Maryland.

Funding decisions are made every two months, and teams can apply for projects in the Technology Assessment phase or the Company Formation phase.

In this cycle, Dr. Peter Searson, Johns Hopkins University Whiting School of Engineering, and Dr. Harry Larman, Johns Hopkins University School of Medicine, have received Technology Assessment awards of $115,000 each. Searson is developing a high-efficiency sensor for cystic fibrosis monitoring that can diagnose electrolyte imbalance in real time.

Larman’s technology will address a critical unmet need for multiplexed 3 molecular analysis of the tumor microenvironment, which they expect will translate into improved implementation of precision immuno-oncology.

Sonoval LLC and Renalert LLC will both receive Company Formation awards of $150,000 each. Sonoval is developing a breakthrough anti-cancer biologic drug therapy for the treatment of a variety of T cell lymphomas and major solid tumors.

Renalert is developing the Renalert System to provide early detection of the onset of acute kidney injury through novel analysis of a patient’s urine output, blood pressure and oxygenation status.

Awards

Good News: July 2018

Good News: July 2018

Startup News

  • Gemstone Biotherapeutics Awarded Grant from National Science Foundation
    The Baltimore-based Johns Hopkins spinout committed to developing technologies for skin regeneration was awarded a Phase I Small Business Innovation Research grant by America’s Seed Fund. The program, powered by the National Science Foundation, provides seed money to the most promising science and technology startups across the country.
  • Perceptive Navigation awarded $3M in federal funding
    The Johns Hopkins spinout was awarded the National Institutes of Health Phase IIB Small Business Innovation Research grant to commercialize its ultrasound system that provides medical imaging from within the body. The company will work to further develop the product and conduct studies as it works toward regulatory approval to market its device.
  • Clear Guide Medical gets $2M grant to develop tools for pediatrics
    The Johns Hopkins spinout has received a $2 million grant from the National Institutes of Health to apply its imaging tools to pediatrics. The company’s SCENERGY device is offered as an accessory to ultrasound systems, and helps provide imaging and guidance of a needle during medical procedures like biopsies, epidurals and tissue removal.
  • Maryland companies raised $247M in venture funding during the second quarter of 2018
    Investors have pumped $247 million in venture capital funding into Maryland companies in the second quarter of 2018, including Johns Hopkins startups LifeSprout and WindMIL.
  • Social Innovation Lab alumni named as The Daily Record’s Very Important Professionals
    The newspaper’s annual VIP List honors professionals 40 years of age and younger who have been successful in Maryland. This year’s list featured Shantell L. Roberts, of Touching Young Lives, Incorporated, and Dr. Panagis Galiatsatos, of Medicine for the Greater Good.
  • Hopkins licensee Allakos Inc. announces pricing of its IPO
    The clinical stage biotechnology company announced the pricing of its initial public offering of more than 7.1 million shares of its common stock at a public offering price of $18 per share. Allakos has raised more than $140M in venture funding to advance a pipeline of drug treatment candidates for various gastrointestinal diseases.

 

Want updates on innovation at Johns Hopkins and in Baltimore? Sign up for our newsletter!

 

WP-Backgrounds Lite by InoPlugs Web Design and Juwelier Schönmann 1010 Wien